Quince Therapeutics, Inc. (QNCX)
Market Open
15 Jun, 14:20
NASDAQ (NGS) NASDAQ (NGS) Primary $
0. 95
+0.02
+2.142%
$
5.2M Market Cap
- P/E Ratio
- Div Yield
59,857 Volume
0 Eps
$ 0.93
Previous Close Analysts:
Want to track QNCX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
QNCX Earnings Reports FAQ
What is the earnings per share (EPS) for QNCX?
The current EPS is 0.
What is the company's earnings growth rate?
Quince Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Quince Therapeutics, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Quince Therapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for QNCX at this time, as Quince Therapeutics, Inc has no recent EPS data to calculate it.
